Recurrent Cutaneous T-cell lymphoma

Also known as: Recurrent T-Cell Lymphoma / Relapsed T-Cell Lymphoma / T-Cell Lymphoma Relapsed / T-cell lymphoma recurrent / T-cell lymphoma NOS recurrent

DrugDrug NameDrug Description
DB02546VorinostatA histone deacetylase (HDAC) inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies.